申请人:Actimis Pharmaceuticals, Inc.
公开号:US08314116B2
公开(公告)日:2012-11-20
Provided herein are 2-S-benzyl pyrimidine compounds having CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity, useful for the prophylaxis and treatment of diseases associated with CRTH2 activity, including the treatment of allergic diseases, eosinophil-related diseases and basophil-related diseases.
本文提供了具有CRTH2(表达在Th2细胞上的G蛋白偶联趋化因子受体)拮抗活性的2-S-苄基嘧啶化合物,用于预防和治疗与CRTH2活性相关的疾病,包括过敏性疾病、嗜酸性粒细胞相关疾病和嗜碱性粒细胞相关疾病的治疗。